| Product NDC: | 0002-4465 |
| Proprietary Name: | Cialis |
| Non Proprietary Name: | Tadalafil |
| Active Ingredient(s): | 2.5 mg/1 & nbsp; Tadalafil |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, FILM COATED |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 0002-4465 |
| Labeler Name: | Eli Lilly and Company |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA021368 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20080107 |
| Package NDC: | 0002-4465-34 |
| Package Description: | 2 BLISTER PACK in 1 CARTON (0002-4465-34) > 15 TABLET, FILM COATED in 1 BLISTER PACK (0002-4465-79) |
| NDC Code | 0002-4465-34 |
| Proprietary Name | Cialis |
| Package Description | 2 BLISTER PACK in 1 CARTON (0002-4465-34) > 15 TABLET, FILM COATED in 1 BLISTER PACK (0002-4465-79) |
| Product NDC | 0002-4465 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Tadalafil |
| Dosage Form Name | TABLET, FILM COATED |
| Route Name | ORAL |
| Start Marketing Date | 20080107 |
| Marketing Category Name | NDA |
| Labeler Name | Eli Lilly and Company |
| Substance Name | TADALAFIL |
| Strength Number | 2.5 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Phosphodiesterase 5 Inhibitor [EPC],Phosphodiesterase 5 Inhibitors [MoA] |